Anagliptin prevented interleukin 1β (IL-1β)-induced cellular senescence in vascular smooth muscle cells through increasing the expression of sirtuin1 (SIRT1)

References

• Sikora E, Bielak-Zmijewska A, Mosieniak G. What is and what is not cell senescence. Postepy Biochem. 2018;64:110–118.
   PubMedGoogle Scholar
• Bernardes de Jesus B, Blasco MA. Assessing cell and organ senescence biomarkers. Circ Res. 2012;111:97–109.
   PubMed Web of Science ®Google Scholar
• Bennett MR, Sinha S, Owens GK. Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res. 2016;118:692–702.
   PubMed Web of Science ®Google Scholar
• Andres V. Vitamin D puts the brakes on angiotensin II-induced oxidative stress and vascular smooth muscle cell senescence. Atherosclerosis. 2014;236:444–447.
   PubMed Web of Science ®Google Scholar
• Grootaert MO, Da Costa Martins PA, Bitsch N, et al. Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis. Autophagy. 2015;11:2014–2032.
   PubMed Web of Science ®Google Scholar
• Chai B, Zheng ZH, Liao X, et al. The protective role of omentin-1 in IL-1beta-induced chondrocyte senescence. Artif Cells Nanomed Biotechnol. 2020;48:8–14.
   PubMed Web of Science ®Google Scholar
• Huang X, You Y, Xi Y, et al. p-Coumaric Acid Attenuates IL-1beta-Induced Inflammatory Responses and Cellular Senescence in Rat Chondrocytes. Inflammation. 2020;43(2):619–628.
   PubMed Web of Science ®Google Scholar
• Matthews C, Gorenne I, Scott S, et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res. 2006;99(2):156–164.
   PubMed Web of Science ®Google Scholar
• Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res. 2018;114(4):622–634.
   PubMed Web of Science ®Google Scholar
• Fei C, Zhao Y, Guo J, et al. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes. Eur J Haematol. 2014;93(6):476–486.
   PubMed Web of Science ®Google Scholar
• Minella AC, Swanger J, Bryant E, et al. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol. 2002;12(21):1817–1827.
   PubMed Web of Science ®Google Scholar
• Choi MR, Kim SH, Ohn T, et al. Resveratrol relieves hydrogen peroxide-induced premature senescence associated with SIRT1 in human mesenchymal stem cells. Mol Cell Toxicol. 2014;10:330–341.
   Web of Science ®Google Scholar
• Freedman DA, Folkman J. CDK2 translational down-regulation during endothelial senescence. Exp Cell Res. 2005;307(1):118–130.
   PubMed Web of Science ®Google Scholar
• Ye Z, Fang J, Dai S, et al. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background. Cancer Lett. 2016;370:216–221.
   PubMed Web of Science ®Google Scholar
• Gardner PJ, Joshi L, Lee RW, et al. SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2/Stat5 signaling. J Autoimmun. 2013;42:117–129.
   PubMed Web of Science ®Google Scholar
• Dong C, Yang H, Wang Y, et al. Anagliptin stimulates osteoblastic cell differentiation and mineralization. Biomed Pharmacother. 2020;129:109796.
   PubMed Web of Science ®Google Scholar
• Hamasaki H, Yanai H. The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin. Int J Cardiol. 2013;168:e106.
   PubMed Web of Science ®Google Scholar
• Nishio S, Abe M, Ito H. Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability. Diabetes Metab Syndr Obes. 2015;8:163–171.
   PubMed Web of Science ®Google Scholar
• Hirano T, Yamashita S, Takahashi M, et al. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits. Metabolism. 2016;65:893–903.
   PubMed Web of Science ®Google Scholar
• Ervinna N, Mita T, Yasunari E, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013;154(3):1260–1270.
   PubMed Web of Science ®Google Scholar
• Jiang T, Jiang D, Zhang L, et al. Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1. Mol Immunol. 2019;107:54–60.
   PubMed Web of Science ®Google Scholar
• Mach F, Schönbeck U, Sukhova GK, et al. CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A. 1997;94(5):1931–1936.
   PubMed Web of Science ®Google Scholar
• Purschwitz K, Rassoul F, Reuter W, et al. Soluble leukocyte adhesion molecules in vegetarians of various ages. Z Gerontol Geriatr. 2001;34(6):476–479.
   PubMed Web of Science ®Google Scholar
• Panayiotou AG, Nicolaides AN, Griffin M, et al. Leukocyte telomere length is associated with measures of subclinical atherosclerosis. Atherosclerosis. 2010;211:176–181.
   PubMed Web of Science ®Google Scholar
• Uryga AK, Bennett MR. Ageing induced vascular smooth muscle cell senescence in atherosclerosis. J Physiol. 2016;594:2115–2124.
   PubMed Web of Science ®Google Scholar
• Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol. 2004;24:546–550.
   PubMed Web of Science ®Google Scholar
• Rodier F, Coppe JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11:973–979.
   PubMed Web of Science ®Google Scholar
• Stein GH, Drullinger LF, Soulard A, et al. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19:2109–2117.
   PubMed Web of Science ®Google Scholar
• Haferkamp S, Becker TM, Scurr LL, et al. p16INK4a-induced senescence is disabled by melanoma-associated mutations. Aging Cell. 2008;7(5):733–745.
   PubMed Web of Science ®Google Scholar
• Lin CP, Lin CS, Lin HH, et al. Bergapten induces G1 arrest and pro-apoptotic cascade in colorectal cancer cells associating with p53/p21/PTEN axis. Environ Toxicol. 2019;34(3):303–311.
   PubMed Web of Science ®Google Scholar
• Han XL, Wu FG, Zhang ZY, et al. Posttranscriptional induction of p21Waf1 mediated by ectopic p16INK4 in human diploid fibroblast. Chin Med J (Engl). 2007;120:405–409.
   PubMed Web of Science ®Google Scholar
• Satoh A, Stein L, Imai S. The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb Exp Pharmacol. 2011;206:125–162.
   PubMedGoogle Scholar
• Xia X, Guo J, Lu F, et al. SIRT1 Plays a Protective Role in Intervertebral Disc Degeneration in a Puncture-induced Rodent Model. Spine (Phila Pa 1976). 2015;40:E515–2.
   PubMed Web of Science ®Google Scholar
• Li B, Li M, Li X, et al. Sirt1-inducible deacetylation of p21 promotes cardiomyocyte proliferation. Aging (Albany NY). 2019;11:12546–12567.
   PubMedGoogle Scholar
• Gu X, Wang Z, Gao J, et al. SIRT1 suppresses p53-dependent apoptosis by modulation of p21 in osteoblast-like MC3T3-E1 cells exposed to fluoride. Toxicol In Vitro. 2019;57:28–38.
   PubMed Web of Science ®Google Scholar
• Cheng QS, Zhang M, Zhang MS, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
   PubMed Web of Science ®Google Scholar
• Li Q, Xiao ZZ, Wang YS, et al. Alterations of long non-coding RNA and mRNA profiles associated with extracellular matrix homeostasis and vascular aging in rats. Bioengineered. 2021;12(1):832–843.
   PubMed Web of Science ®Google Scholar
• Kunieda T, Minamino T, Nishi J, et al. II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation. 2006 Aug 29;114(9):953–960.
   PubMed Web of Science ®Google Scholar
• Bennett MR, Macdonald K, Chan SW, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998 Apr 6;82(6):704–712.
   PubMed Web of Science ®Google Scholar
• Papagianni M, Tziomalos K. Cardiovascular effects of dipeptidyl peptidase-4 inhibitors. Hippokratia. 2015 Jul-Sep;19(3):195–199.
   PubMed Web of Science ®Google Scholar
• Rankovic M, Jeremic N, Srejovic I, et al. Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection. Heart Fail Rev. 2021 Mar;26(2):437–450.
   PubMed Web of Science ®Google Scholar